XIth Eurasian Hematology-Oncology Congress - EHOC 2020
Leukemic Transformations of MPNs: What Mutations Are Associated With an Increased Risk? What Is the Efficacy of Standard Induction Therapy in Post-MPN AML? Does AlloSCT Offer Any Benefit?
Comments 0
Login to view comments.
Click here to Login
